Godavari Biorefineries partners with Synthomer for bio-based monomers

Marquee Jv AnnouncedStrategic Transactions View source PDF Explain this filing

GODAVARIB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+8.8%Reaction day

₹253.95

prior close

₹263.30

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%+9.6% vs market

Fast Moving Consumer Goods peers, median of 285sector · sector level+0.0%+8.8% vs sector

On the reaction day the stock moved 9.6 pts more than Nifty Microcap 250 and 8.8 pts more than its Fast Moving Consumer Goods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

+0.1

15m

+0.5

30m

+3.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+8.8-0.8+9.6+0.0+8.8

Next day

+13.7+1.8+11.9+1.3+12.4

+15.2+2.8+12.4+2.1+13.1

+16.5+2.3+14.3+1.9+14.6

+13.0+1.8+11.3+0.7+12.3

+10.6+0.3+10.3+0.2+10.4

+9.9+0.5+9.4+0.0+9.9

15d

+15.0-2.5+17.5-1.8+16.8

+14.2-6.3+20.5-4.4+18.6

+22.0-8.0+29.9-6.5+28.5

+23.0+8.3+14.8+3.2+19.8

UpDownMarket · Nifty Microcap 250Sector · Fast Moving Consumer Goods peers, median of 285Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Godavari Biorefineries (GBL) has partnered with UK-based Synthomer to develop bio-based alternatives to fossil-based monomers. Synthomer will commercialise bio-based butyl acrylate using bio-based butanol produced by GBL. The collaboration supports demand for sustainable, lower-carbon raw materials and aligns with GBL's sustainability strategy. Synthomer is a London-listed global polymer supplier with around 3,900 employees.

Likely market impact

Positive for long-term growth; partnership with a major global player strengthens bio-based chemicals business, though near-term financial impact is unclear.